Skip to main content
Caplight Logo









mycoBiologics Ltd

mycoBiologics Ltd

Private
AberdeenHealthcare & Life Scienceshttps://mycobiologics.com/

Last Round

Grant

Dec 12, 2025

Total Funding Raised

$640,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

mycoBiologics Ltd is a biotechnology company that develops patient-derived human monoclonal antibody therapies for the treatment of life-threatening, drug-resistant fungal infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodymAbantifungal therapybiotechdrug-resistant infectiondrug discoveryCandidabiologicstherapeutic pipelinepre-clinical researchpharma licensingsuperbuginfectious disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

mycoBiologics Ltd Comparables

Compare mycoBiologics Ltd with similar companies based on industry and business-model similarity.

mycoBiologics Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brigid Bio Ltd
95%
Bright Angel Therapeutics
81%
Biosergen AB
63%

mycoBiologics Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 12, 2025
GrantFeb 23, 2025
GrantMar 22, 2019

Key People

Founding team and executive leadership

Fiona Rudkin

Founder CEO

Founding Team

mycoBiologics Ltd Investors

Notable investors and investment history

mycoBiologics Ltd investors
InvestorRounds
INCATEGrant
Scottish EDGEGrant
Scottish Investment Bank (Scottish Enterprise)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 12, 2025

    $110K grant awarded by Scottish EDGE.

  • Mar 22, 2019

    $520K grant received from Scottish Investment Bank.

mycoBiologics Ltd Filings

Explore SEC and related filing metadata, where available.

mycoBiologics Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about mycoBiologics Ltd's valuation, stock price, and market status.

Is mycoBiologics Ltd a public or private company?

mycoBiologics Ltd is a private company.

What is the current stock price of mycoBiologics Ltd?

mycoBiologics Ltd is a private company with no public stock price. No recent secondary market data is available.

How much is mycoBiologics Ltd worth (valuation)?

Valuation information for mycoBiologics Ltd is not publicly available.

Can I buy mycoBiologics Ltd stock?

mycoBiologics Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was mycoBiologics Ltd's last funding round?

mycoBiologics Ltd's most recent funding round was Grant on December 12, 2025.

Who are the main investors in mycoBiologics Ltd?

Key investors in mycoBiologics Ltd include INCATE, Scottish EDGE, Scottish Investment Bank (Scottish Enterprise).

Will mycoBiologics Ltd IPO soon?

No public IPO plans have been announced for mycoBiologics Ltd.

How can I track mycoBiologics Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor mycoBiologics Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAberdeen
Employee Range3
Year Founded2020
Last FundingDec 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?